Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study
BRITISH JOURNAL OF HAEMATOLOGY（2019）
关键词
follicular lymphoma,interferon,long-term toxicity,survival
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要